To include your compound in the COVID-19 Resource Center, submit it here.

Oxygen slides on Oxycyte trial halt

Oxygen Biotherapeutics Inc. (NASDAQ:OXBT) fell $0.36 to $3.70 in early after-hours trading on Thursday after announcing

Read the full 165 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE